Haifa, Israel

Nitzan Shany

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 10.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Nitzan Shany: Innovator in Medical Technology

Introduction

Nitzan Shany is a prominent inventor based in Haifa, Israel. He has made significant contributions to the field of medical technology, particularly in the development of devices aimed at treating tumors. With a total of 2 patents to his name, Shany's work is at the forefront of innovation in healthcare.

Latest Patents

One of Nitzan Shany's latest patents is a medical treatment device that features a shiftable transducer array with an anisotropic material layer. This transducer apparatus is designed to deliver tumor-treating fields to a subject's body. The apparatus includes an array of electrodes that can be positioned over the subject's body, with a front face of the array facing the body. The array comprises electrode elements arranged around a centroid, and it is coupled with an anisotropic material layer located on the front side of the array. Additionally, the design incorporates at least one void space capable of enclosing an areal footprint equivalent to existing electrode positions, allowing for rotation around the centroid.

Career Highlights

Nitzan Shany is currently associated with Novocure GmbH, a company known for its innovative approaches to cancer treatment. His work at Novocure has been instrumental in advancing medical technologies that improve patient outcomes.

Collaborations

Shany collaborates with talented professionals in his field, including Boaz Marsault and Elie Yaacobi. These partnerships enhance the innovative capabilities of his projects and contribute to the development of cutting-edge medical solutions.

Conclusion

Nitzan Shany is a key figure in the realm of medical technology, with a focus on devices that address critical health challenges. His contributions through patents and collaborations reflect his commitment to improving treatment options for patients.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…